https://www.businesswire.com/news/home/20250202168953/en/Inhalon-Biopharma-Announces-First-of-its-Kind-Inhaled-Antibody-Treatment-for-RSV-to-Enter-Human-Clinical-Trials
Inhalon Biopharma Announces First-of-its-Kind Inhaled Antibody Treatment for RSV to Enter Human...
Inhalon Biopharma's inhaled RSV antibody treatment will enter human trials marking a potential breakthrough in respiratory disease treatment.
first of its kind